Interleukin-31 Receptor α Is Required for Basal-Like Breast Cancer Progression
Conclusion: Overall, these data indicate that IL31RA promotes basal-like breast cancer progression and metastasis, suggesting that targeting of IL-31/IL31RA axis might be beneficial to treatment of BLBC.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
More News: Allergy & Immunology | Breast Cancer | Cancer | Cancer & Oncology | Genetics | Stem Cell Therapy | Stem Cells